Concepedia

Sarah Alter

SA

Statistics

Publications

11

Citations

1.1K

H-Index

11

Active since

2013

Affiliations

Altor BioScience (United States)(Current)

University of Wisconsin–Madison

University of Minnesota Medical Center

University of Miami

National Institutes of Health

Sarah Alter is an author at Altor BioScience (United States) specializing in immunology, cancer immunotherapy, and life sciences.

Publications per year

2013–2019

11

Publications

11

Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models

Peter R. Rhode, Jack O. Egan, Wenxin Xu et al. · Cancer Immunology Research · 2015 · 225 citations · Full text

Life Sciences, Immunology, Oncology +13

In senescence, age‐associated B cells secrete <scp>TNF</scp>α and inhibit survival of B‐cell precursors*

Michelle Ratliff, Sarah Alter, Daniela Frasca et al. · Aging Cell · 2013 · 182 citations · Full text

Life Sciences, Cell Biology, Immunology +17

IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas

Peter Kim, Anna Kwilas, Wenxin Xu et al. · Oncotarget · 2016 · 157 citations · Full text

Life Sciences, Immunology, Oncology +17

Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy

Karin M. Knudson, Kristin C. Hicks, Sarah Alter et al. · Journal for ImmunoTherapy of Cancer · 2019 · 113 citations · Full text

Life Sciences, Immunology, Oncology +17

Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model

Dimitrios Mathios, Chul‐Kee Park, Warren D. Marcus et al. · International Journal of Cancer · 2015 · 104 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 11